South Western Sydney Clinical School

Walker GJ; Harrison JW; Heap GA; Voskuil MD; Andersen V; Anderson CA; Ananthakrishnan AN; Barrett JC; Beaugerie L; Bewshea CM, 2019, 'Association of Genetic Variants in NUDT15 with Thiopurine-Induced Myelosuppression in Patients with Inflammatory Bowel Disease', JAMA - Journal of the American Medical Association, vol. 321, pp. 753 - 761, http://dx.doi.org/10.1001/jama.2019.0709

Connor S, 2018, 'What can Australian Inflammatory Bowel Disease Association achieve in the next 3 to 5 years?', Journal of Gastroenterology and Hepatology (Australia), vol. 33, pp. 35, http://dx.doi.org/10.1111/jgh.14437

Liu F; Ma R; Tay CYA; Octavia S; Lan R; Chung HKL; Riordan SM; Grimm MC; Leong RW; Tanaka MM, 2018, 'Genomic analysis of oral Campylobacter concisus strains identified a potential bacterial molecular marker associated with active Crohn's disease', Emerging Microbes and Infections, vol. 7, http://dx.doi.org/10.1038/s41426-018-0065-6

Doecke JD; Hartnell F; Bampton P; Bell S; Mahy G; Grover Z; Lewindon P; Jones LV; Sewell K; Krishnaprasad K, 2017, 'Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study', Alimentary Pharmacology and Therapeutics, vol. 45, pp. 542 - 552, http://dx.doi.org/10.1111/apt.13880

Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI, 2017, 'Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse', Gastrointestinal Endoscopy, vol. 86, pp. 1070 - 1078, http://dx.doi.org/10.1016/j.gie.2017.09.011

Chen GB; Lee SH; Montgomery GW; Wray NR; Visscher PM; Gearry RB; Lawrance IC; Andrews JM; Bampton P; Mahy G, 2017, 'Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method', BMC Medical Genetics, vol. 18, http://dx.doi.org/10.1186/s12881-017-0451-2

Bye WA; Sparrow MP; Connor SJ; Andrews JM; Ellard K; Ng W; Hume G; Antoniades S; Walsh AJ, 2017, 'The need for better preventative strategies for inflammatory bowel disease patients at risk of herpes zoster virus', Internal Medicine Journal, vol. 47, pp. 1263 - 1269, http://dx.doi.org/10.1111/imj.13488

Mitrev N; Vande Casteele N; Seow CH; Andrews JM; Connor SJ; Moore GT; Barclay M; Begun J; Bryant R; Chan W, 2017, 'Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases', Alimentary Pharmacology and Therapeutics, vol. 46, pp. 1037 - 1053, http://dx.doi.org/10.1111/apt.14368

Lawrance IC; Baird A; Lightower D; Radford-Smith G; Andrews JM; Connor S, 2017, 'Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis', Clinical Gastroenterology and Hepatology, vol. 15, pp. 1248 - 1255, http://dx.doi.org/10.1016/j.cgh.2017.02.027

Toong CML; Lee MWM; Connor S; Ng W, 2017, 'Response to: Comparison of infliximab drug measurement across three commercially available ELISA kits: author reply', Pathology, vol. 49, pp. 334 - 335, http://dx.doi.org/10.1016/j.pathol.2017.01.005

Paramsothy S; Kamm MA; Kaakoush NO; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R, 2017, 'Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial', The Lancet, vol. 389, pp. 1218 - 1228, http://dx.doi.org/10.1016/S0140-6736(17)30182-4

Feagan BG; Sandborn WJ; Gasink C; Jacobstein D; Lang Y; Friedman JR; Blank MA; Johanns J; Gao LL; Miao Y, 2016, 'Ustekinumab as induction and maintenance therapy for Crohn's disease', New England Journal of Medicine, vol. 375, pp. 1946 - 1960, http://dx.doi.org/10.1056/NEJMoa1602773

Elnawsra O; Fok I; Sparrow M; Gibson P; Andrews J; Connor S, 2016, 'Faecal calprotectin: Current usage and perceived beneficial effects of third-party funding on rates of colonoscopy by Australian gastroenterologists', Internal Medicine Journal, vol. 46, pp. 590 - 595, http://dx.doi.org/10.1111/imj.13056

Stein J; Connor S; Virgin G; Ong DEH; Pereyra L, 2016, 'Anemia and iron deficiency in gastrointestinal and liver conditions', World Journal of Gastroenterology, vol. 22, pp. 7908 - 7925, http://dx.doi.org/10.3748/wjg.v22.i35.7908

Andrews JM; Costello SP; Agarwal AK; Bampton P; Beswick L; Connor S; Ghaly S; O'Connor S; Pudipeddi A; Sechi A, 2016, 'Conflict of interest: Real and perceived - a more mature consideration is needed', Internal Medicine Journal, vol. 46, pp. 377 - 379, http://dx.doi.org/10.1111/imj.12989

Julsgaard M; Christensen LA; Gibson PR; Gearry RB; Fallingborg J; Hvas CL; Bibby BM; Uldbjerg N; Connell WR; Rosella O, 2016, 'Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection', Gastroenterology, vol. 151, pp. 110 - 119, http://dx.doi.org/10.1053/j.gastro.2016.04.002

Connor SJ, 2016, 'Biologic Therapeutic Drug Monitoring in Australia', Journal of Gastroenterology and Hepatology (Australia), vol. 31, pp. 8 - 9, http://dx.doi.org/10.1111/jgh.13346

Chen JH; Andrews JM; Kariyawasam V; Moran N; Gounder P; Collins G; Walsh AJ; Connor S; Lee TWT; Koh CE, 2016, 'Review article: Acute severe ulcerative colitis - Evidence-based consensus statements', Alimentary Pharmacology and Therapeutics, vol. 44, pp. 127 - 144, http://dx.doi.org/10.1111/apt.13670

Thompson KD; Connor SJ; Walls DM; Gollins J; Stewart SK; Bewtra M; Baumblatt GL; Holubar SD; Greenup AJ; Sechi A, 2016, 'Patients with ulcerative colitis are more concerned about complications of their disease than side effects of medications', Inflammatory Bowel Diseases, vol. 22, pp. 940 - 947, http://dx.doi.org/10.1097/MIB.0000000000000740

Ghaly S; Costello S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; Antoniades S; Headon B; Connor S; Lawrance IC, 2015, 'Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response', Internal Medicine Journal, vol. 45, pp. 170 - 177, http://dx.doi.org/10.1111/imj.12621

Paramsothy S; Walsh AJ; Borody T; Samuel D; Van Den Bogaerde J; Leong RWL; Connor S; Ng W; Mitchell HM; Kaakoush NO, 2015, 'Gastroenterologist perceptions of faecal microbiota transplantation', World Journal of Gastroenterology, vol. 21, pp. 10907 - 10914, http://dx.doi.org/10.3748/wjg.v21.i38.10907

Ko Y; Kariyawasam V; Karnib M; Butcher R; Samuel D; Alrubaie A; Rahme N; McDonald C; Cowlishaw J; Katelaris P, 2015, 'Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to Australia', Clinical Gastroenterology and Hepatology, vol. 13, pp. 1453 - 1463.e1, http://dx.doi.org/10.1016/j.cgh.2015.02.045

Paramsothy S; Borody TJ; Lin E; Finlayson S; Walsh AJ; Samuel D; Van Den Bogaerde J; Leong RWL; Connor S; Ng W, 2015, 'Donor recruitment for fecal microbiota transplantation', Inflammatory Bowel Diseases, vol. 21, pp. 1600 - 1606, http://dx.doi.org/10.1097/MIB.0000000000000405

Costello SP; Ghaly S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; O'Connor S; Connor SJ; Sparrow MP; Bampton P, 2015, 'Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: The benefits to patients', Internal Medicine Journal, vol. 45, pp. 659 - 666, http://dx.doi.org/10.1111/imj.12732

Ghaly S; Costello S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; Headon B; Prosser R; Connor S; Lawrance IC, 2014, 'Short term dose tailoring of anti TNF-alpha therapy delivers useful clinical efficacy in Crohn's disease patients with secondary loss of response', JOURNAL OF CROHNS & COLITIS, vol. 8, pp. S209 - S209, http://dx.doi.org/10.1016/S1873-9946(14)60466-9

Sze KCP; Ng WSW; Connor SJ, 2014, 'Thiopurine metabolite monitoring and allopurinol combination therapy: current utilisation and influence on Australian gastroenterology IBD practice', JOURNAL OF CROHNS & COLITIS, vol. 8, pp. S194 - S194, http://dx.doi.org/10.1016/S1873-9946(14)60432-3

Julsgaard M; Christensen LA; Lawrence I; Gearry R; Connell W; Grosen A; Svenningsen L; Andrews JM; Bampton P; Walsh A, 2014, 'Pregnancy outcome and counselling of anti-TNF-alpha treated IBD women: an ongoing international multicentre study', JOURNAL OF CROHNS & COLITIS, vol. 8, pp. S222 - S223, http://dx.doi.org/10.1016/S1873-9946(14)60497-9

Julsgaard M; Christensen LA; Fallingborg J; Gearry R; Radford-Smith G; Walsh A; Kjeldsen J; Sparrow MP; Andrews JM; Connor SJ, 2014, 'Intra-uterine ExposuRe to Anti-TNF-alpha therapy (ERA study): Infliximab and adalimumab cord blood levels correlate with maternal levels at birth', JOURNAL OF CROHNS & COLITIS, vol. 8, pp. S34 - S35, http://dx.doi.org/10.1016/S1873-9946(14)60066-0

Heap GA; Weedon MN; Bewshea CM; Singh A; Chen M; Satchwell JB; Vivian JP; So K; Dubois PC; Andrews JM, 2014, 'HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants', Nature Genetics, vol. 46, pp. 1131 - 1134, http://dx.doi.org/10.1038/ng.3093

Hussain MI; Hall BM; Depczynski B; Connor SJ, 2014, 'Acute renal failure and metformin-associated lactic acidosis following colonoscopy', Diabetes Research and Clinical Practice, http://dx.doi.org/10.1016/j.diabres.2013.12.055

Walsh AJ; Weltman M; Burger D; Travis SPL; Vivekanandarajah S; Connor S; Howlett M; Radford-Smith G; Selby W; Veillard AS, 2013, 'Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease', Journal of Crohn's and Colitis, http://dx.doi.org/10.1016/j.crohns.2013.02.019

Aggarwal V; Day A; Leach S; Connor SJ; Brown GJ; Singh R; Freidman A; Grimm M; Craig P, 2012, 'Multicenter capsule endoscopy study of patients with small bowel Crohn's disease in clinical remission: long-term follow-up and correlation with faecal biomarkers and clinical outcome', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 27, pp. 96 - 97, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308642600201&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fok KC; Ng WWS; Henderson CJA; Connor SJ, 2012, 'Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab', Journal of Crohn's and Colitis, vol. 6, pp. 708 - 712, http://dx.doi.org/10.1016/j.crohns.2012.01.008

Koo JH; You MY; Liu K; Athureliya MD; Tang CWY; Redmond DM; Connor SJ; Leong RWL, 2012, 'Colorectal cancer screening practise is influenced by ethnicity of medical practitioner and patient', Journal of Gastroenterology and Hepatology (Australia), vol. 27, pp. 390 - 396, http://dx.doi.org/10.1111/j.1440-1746.2011.06872.x

Ellard K; Connor S, 2011, 'How to treat', Australian Doctor, pp. 27 - 34

Koo JH; Arasaratnam MM; Liu K; Redmond DM; Connor SJ; Sung JJY; Leong RWL, 2010, 'Knowledge, perception and practices of colorectal cancer screening in an ethnically diverse population', Cancer Epidemiology, vol. 34, pp. 604 - 610, http://dx.doi.org/10.1016/j.canep.2010.05.013

Guirgis M; Manoharan S; Scott DR; Kwok R; Lee AU; Connor SJ; Levy MT, 2009, 'Transient elastography (Fibroscan) in chronic hepatitis B infection: reduce number of biopsies & save money', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 24, pp. A308 - A308, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200238&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thomson AD; Ng WSW; Connor SJ, 2009, 'Response to infliximab in patients with steroid refractory and steroid dependent ulcerative colitis', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 24, pp. A317 - A318, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200263&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Koo JH; Athureliya MD; Tang CWY; Liu K; Wickramaratne H; Redmond D; Connor SJ; Leong RWL, 2009, 'Colorectal cancer screening practice is influenced by ethnicity of patient and general practitioner', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 24, pp. A224 - A224, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Siriwardana AS; Koo JH; Ng WSW; Connor SJ, 2009, 'Azathioprine, 6-mercaptopurine and thiopurine s-methyltransferase levels in gastroenterology and rheumatology: a comparison of clinical practice in Australia', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 24, pp. A222 - A223, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Siriwardana AS; Koo JH; Ng WSW; Connor SJ, 2009, 'Azathioprine, 6-mercaptopurine and thiopurine s-methyltransferase levels in inflammatory bowel disease: what is current clinical practice?', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 24, pp. A311 - A312, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200246&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Koo JH; Jalaludin B; Wong SKC; Kneebone A; Connor SJ; Leong RWL, 2008, 'Improved survival in young women with colorectal cancer', American Journal of Gastroenterology, vol. 103, pp. 1488 - 1495, http://dx.doi.org/10.1111/j.1572-0241.2007.01779.x

Koo JH; Kin S; Wong C; Jalaludin B; Kneebone A; Connor SJ; Leong RWL, 2008, 'Clinical and Pathologic Outcomes of Colorectal Cancer in a Multi-Ethnic Population', Clinical Gastroenterology and Hepatology, vol. 6, pp. 1016 - 1021, http://dx.doi.org/10.1016/j.cgh.2008.03.018

Wiseman E; Gilbert D; Schlaphoff G; Chow C; Levy M; Connor S, 2006, 'Adequacy of liver biopsies: size does matter', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 21, pp. A248 - A248, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247320600003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Koo JHK; Jalaludin B; Wong SKC; Poxon V; Kneebone A; Connor SJ; Leong RWL, 2006, 'Colorectal cancer in females is associated with poorer outcomes', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 21, pp. A266 - A266, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247320600039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Koo JHK; Kneebone A; Connor SJ; Jalaludin B; Poxon V; Wong SKC; Leong RWL, 2006, 'The impact of ethnicity and culture on clinical outcomes of colorectal cancer in South Western Sydney', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 21, pp. A281 - A281, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247320600069&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chin BW; Grimm MC; Connor SJ; Leong RW, 2006, 'Managing inflammatory bowel disease', Medicine Today, vol. 7, pp. 14 - 23

Newman R; Cuan N; Hampartzoumian T; Connor SJ; Lloyd AR; Grimm MC, 2005, 'Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis', Clinical and Experimental Immunology, vol. 139, pp. 411 - 420, http://dx.doi.org/10.1111/j.1365-2249.2005.02673.x

Connor SJ; Paraskevopoulos N; Newman R; Cuan N; Hampartzoumian T; Lloyd AR; Grimm MC, 2004, 'CCR2 expressing CD4⁺ T lymphocytes are preferentially recruited to the ileum in Crohn's disease', Gut, vol. 53, pp. 1287 - 1294, http://dx.doi.org/10.1136/gut.2003.028225

Grimm MC; Newman R; Hassim Z; Cuan N; Connor SJ; Le Y; Wang JM; Oppenheim JJ; Lloyd AR, 2003, 'Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans-Deactivating Chemokine Receptors', Journal of Immunology, vol. 171, pp. 4990 - 4994, http://dx.doi.org/10.4049/jimmunol.171.10.4990

Connor SJ; Grimm MC, 2001, 'Heparin as an anti-inflammatory agent: It's no GAG to forget about chemokines [3]', Gut, vol. 48, pp. 738, http://dx.doi.org/10.1136/gut.48.5.738

Connor SJ; Cardillo R; Cuan N; Amansec S; Conway P; Lloyd AR; Grimm MC, 2001, 'Amelioration of TNBS colitis in mice using prebiotics', GASTROENTEROLOGY, vol. 120, pp. A82 - A82, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000168514700403&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Connor SJ; Hassim Z; Cardillo R; Lloyd AR; Grimm MC, 2000, 'Chemokine receptor expression and function in lamina propria mononuclear cells of the human colon.', GASTROENTEROLOGY, vol. 118, pp. A355 - A355, http://dx.doi.org/10.1016/S0016-5085(00)83524-6

Connor SJ; Ngu MC; Katelaris PH, 1999, 'The impact of short-term ranitidine use on the precision of the ¹³C-urea breath test in subjects infected with Helicobacter pylori', European Journal of Gastroenterology and Hepatology, vol. 11, pp. 1135 - 1138, http://dx.doi.org/10.1097/00042737-199910000-00010

Connor SJ; Seow F; Ngu MC; Katelaris PH, 1999, 'The effect of dosing with omeprazole on the accuracy of the ¹³C-urea breath test in Helicobacter pylori-infected subjects', Alimentary Pharmacology and Therapeutics, vol. 13, pp. 1287 - 1293, http://dx.doi.org/10.1046/j.1365-2036.1999.00601.x

Khin-Maung-U; Tin-Aye; Ku-Tin-Myint; Tin-Oo; Myo-Khin; Thackway SA; Connor SJ; Bolin TD; Duncombe VM, 1992, 'In vitro hydrogen production by enteric bacteria cultured from children with small bowel bacterial overgrowth', Journal of Pediatric Gastroenterology and Nutrition, vol. 14, pp. 192 - 197, http://dx.doi.org/10.1097/00005176-199202000-00013

Krishnaprasad K; Walsh A; Begun J; Bell S; Carter D; Grafton R; Sechi A; Sewell K; Mcmahon A; Connor S, 2017, 'Crohn's Colitis Care (CCCare): A bespoke cloud-based clinical management system for inflammatory bowel disease - development and beta testing', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 131 - 131, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100237&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pulusu SSR; Krishnaprasad K; Cheng D; Mogilevski T; Flanagan E; Parthasarathy N; Wu C; Prosser R; Sawyer E; Rizvi QUA, 2017, 'Vedolizumab: Real-life outcomes to therapy in Crohn's disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 143 - 143, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100256&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pulusu SSR; Krishnaprasad K; Cheng D; Mogilevski T; Flanagan E; Parthasarathy N; Wu C; Prosser R; Sawyer E; Rizvi Q-U-A, 2017, 'Vedolizumab: Real-life outcomes to therapy in ulcerative colitis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 142 - 142, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Verdon C; Sawyer E; Connor S; Ng W; Turner I, 2017, 'Drug-induced systemic lupus erythematosus in patients with inflammatory bowel disease treated with anti-tumor necrosis factor inhibitors: A case series', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 150 - 150, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100268&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mitrev N; Vande Casteele N; Seow C; Andrews JM; Connor SJ; Moore G; Barclay M; Begun J; Bryant R; Chan W, 2017, 'Therapeutic drug monitoring-guided biological drug therapy in inflammatory bowel disease: Consensus statements of the Australian Inflammatory Bowel Disease Association (AIBDA) and Gastroenterological', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 136 - 138, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100247&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lin B; Wu Y; Thilakanathan C; Lehmann P; Xuan W; Mohsen W; Toong C; Ng W; Connor S, 2017, 'Biological level testing in inflammatory bowel disease identifies inappropriate use of infliximab, with substantial associated cost savings', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 132 - 133, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100240&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nguyen MTA; Antoniades S; Xuan W; Ghaly S; Connor S; Ng W, 2017, 'Treatment of ulcerative colitis with infliximab: Real-world outcomes are better than pivotal trials and improved with dose intensification', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 139 - 139, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100249&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wen A; Selvanderan SP; Wu Y; Xuan W; Andrews JM; Koo JH; Ng W; Connor S, 2017, 'Assessment of anti-tumor necrosis factor drug levels in people with Crohn's disease changes management decisions more often when done for loss of response than during remission', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 152 - 152, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100271&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Seang S; Kanazaki R; Krishnaprasad K; Hanigan K; Bampton P; Prosser R; Andrews J; Grafton R; Mahy G; Bell S, 2017, 'Clinical predictors of severe ulcerative colitis requiring colectomy in Australia', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 145 - 145, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wu Y; Lin B; Thilakanathan C; Lehmann P; Xuan W; Mohsen W; Toong C; Ng W; Connor S, 2017, 'Secondary loss of response is the most common indication for infliximab level testing in inflammatory bowel disease: The Australian experience', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 153 - 154, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100273&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Kamm MA; Walsh A; van den Bogaerde J; Samuel D; Leong RW; Connor SJ; Ng WSW; Paramsothy R; Kaakoush N, 2016, 'Multi Donor Intense Faecal Microbiota Transplantation is an Effective Treatment for Resistant Ulcerative Colitis: A Randomised Placebo-Controlled Trial', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, San Diego, CA, pp. S122 - S123, presented at Digestive Disease Week (DDW), San Diego, CA, 20 - 24 May 2016, http://dx.doi.org/10.1016/S0016-5085(16)30517-0

Sechi A; Sawyer E; Ng W; Connor S, 2016, 'Proving cost effectiveness through implementation of a nurse-led inflammatory bowel disease patient advice line and virtual clinic (CHEAP)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 174 - 174, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700314&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sechi A; Sawyer E; Ng W; Connor S, 2016, 'Proving cost effectiveness through implementation of a nurse-led inflammatory bowel disease patient advice line and virtual clinic (CHEAP)', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S494 - S494, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374496600879&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chen J-H; Corte CJ; Kariyawasam VC; Moran N; Gounder P; Collins GD; Connor SJ; Lee T; Walsh A; Koh CE, 2015, 'Consensus Statements on the Management of Acute Severe Ulcerative Colitis', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, Washington, DC, pp. S408 - S408, presented at 46th Annual Digestive Disease Week (DDW), Washington, DC, 16 - 19 May 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360117100027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hsu J; Greenup A; Kordian T; Sze K; Bassan M; Koo K; Ng W; Connor S, 2015, 'A single-blinded, randomised clinical trial: comparison between 2 different bowel preparation formulations split PrepKitC, a combined polyethylene glycol and sodium picosulfate-based solution and spli', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 45 - 45, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364505900088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ko Y; Paramsothy S; Sarathy K; Shan P; Ng W; Connor S, 2015, 'Bone health in inflammatory bowel disease patients - management by australian gastroenterologists is variable and poorly consistent with current guidelines', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 131 - 131, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364505900255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ooi S-YJ; Gounder M; Grafton R; Leach P; Sechi A; Ng W; Connor S; Bampton P; Andrews JM, 2015, 'Are we under-recognizing skewed thiopurine metabolism in IBD patients? Routine thiopurine metabolite measurement yields clinical benefit at 12 months: A retrospective observational study.', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S255 - S255, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000353811200469&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ooi S-YJ; Gounder M; Grafton R; Leach P; Sechi A; Ng W; Connor S; Bampton P; Andrews JM, 2015, 'Thiopurine metabolite testing to guide management in inflammatory bowel disease (IBD) yields clinical benefit at 12 months: A retrospective observational study.', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S290 - S290, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000353811200536&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Costello S; Ghaly S; O'Connor S; Agarwal A; Beswick L; Headon B; Pudipeddi A; Sechi A; Prosser R; Connor S, 2014, 'Compassionate access use of anti-TNF therapy in ulcerative colitis in six Australian IBD centres has been beneficial to patient outcomes', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S288 - S288, http://dx.doi.org/10.1016/S1873-9946(14)60649-8

Paramsothy S; Sarathy K; Ng W; Connor S, 2014, 'Bone health management in inflammatory bowel disease patients amongst Australian gastroenterologists', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S177 - S177, http://dx.doi.org/10.1016/S1873-9946(14)60394-9

Ooi SY; Gounder M; Grafton R; Leach P; Bampton P; Ng W; Connor S; Andrews JM, 2014, 'Thiopurine metabolite monitoring in inflammatory bowel disease (IBD): A retrospective observational study evaluating the longer-term outcomes (>= 12 months) of metabolite level led clinical management', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 122 - 122, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000240&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ghaly S; Costello S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; Headon B; Connor S; Sparrow M; Walsh AJ, 2013, 'Compassionate access use of anti-TNF therapy in Crohn's disease reduces the need for steroids in an Australian multicenter retrospective review', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 105 - 106, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900223&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Julsgaard M; Christensen LA; Gearry R; Andrews J; Rosella O; Connor S; Walsh A; Brown S; Connell W; Gibson P, 2013, 'Intra-uterine exposure to anti-TNF-alpha therapy (ERA study): Neonatal levels of anti TNF antibodies correlate with duration of therapy in pregnancy', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 85 - 85, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Sarathy K; Ng W; Connor S, 2013, 'Bone health in inflammatory bowel disease patients - a survey of australian gastroenterologists', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 107 - 107, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900227&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Costello S; Ghaly S; Beswick L; Pudipeddi A; Agarwal A; Headon B; Seschi A; Connor S; Sparrow M; Walsh A, 2013, 'Compassionate access use of Anti-TNF therapy in Ulcerative Colitis in four Australian IBD centres has been beneficial to patient outcomes', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 105 - 105, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sze KCP; Sechi A; Ng W; Connor S, 2013, 'Thiopurine use and metabolites monitoring in inflammatory bowel disease: Current practice in Australia', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 97 - 97, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Greenup A-J; Koo J; Sechi A; Levy M; Ng W; Connor S, 2013, 'Prospective single-blinded single-centre randomized controlled trial comparing moviprep with prepkit c using standard split preparation protocol in patients for elective colonoscopy', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 19 - 20, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

De Cruz P; Kamm MA; Hamilton AL; Ritchie KJ; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA, 2012, 'Adalimumab Prevents Post-Operative Crohn's Disease Recurrence, and is Superior to Thiopurines: Early Results From the POCER Study', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, San Diego, CA, pp. S212 - S212, presented at Digestive Disease Week (DDW), San Diego, CA, 19 - 22 May 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306994301140&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Aggarwal V; Day AS; Connor S; Leach ST; Grimm M; Craig PI, 2010, 'Correlation between capsule endoscopy findings and Crohn's disease activity index, faecal calprotectin and S100A12 in small bowel Crohn's disease patients in clinical remission', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A100 - A100, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200272&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Guirgis M; Manoharan S; Kwok R; Scott DR; Lee AU; Connor SJ; Levy M, 2009, 'TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN CHRONIC HEPATITIS B INFECTION: REDUCE NUMBER OF BIOPSIES & SAVE MONEY', in HEPATOLOGY, JOHN WILEY & SONS INC, Boston, MA, pp. 543A - 543A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 30 October - 03 November 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456000499&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Holden SL; Connor S; Quinn J; Levy MT, 2008, 'Is there still a role for lamivudine? Baseline HBeAg status and viral load at 6 and 12 months predicts long-term effectiveness of lamivudine in CHB patients', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A186 - A186, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259960100024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Koo JH; Arasaratnam MM; Liu K; Redmond D; Connor SJ; Leong RWL, 2008, 'Improving participation in colorectal cancer screening in a multi-ethnic population', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A205 - A205, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259960100062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kordian T; Greenup AJ; Ng WSW; Koo KJH; Connor SC, 2014, 'Prospective single-blinded single-centre randomized controlled trial in comparing Moviprep, a polyethylene glycol-based solution with PrepKit C, a combined polyethylene glycol and sodium picosulfate-b', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 29, pp. 136 - 136, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000267&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sze KCP; Siriwardana A; Sechi A; Ng WSW; Connor SJ, 2014, 'Thiopurine prescribing and monitoring behaviour, including metabolites testing and allopurinol co-therapy: an Australian perspective from 2008 to 2013', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 29, pp. 114 - 114, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000224&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mohsen W; Wark G; Greenup A; Sechi A; Sawyer E; Koo JH; Ng W; Connor S, 2017, 'Prospective, single-blinded, single-center randomized controlled trial comparing outcomes of bowel preparation for colonoscopy using MoviPrep or Prepkit-C in patients with or without inflammatory bowe', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 32, pp. 25 - 25, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kim AH; Sechi AJ; Ruban SO; Ng W; Girgis A; Andrews JM; Siegel CA; Connor SJ, 2017, 'Feasibility and acceptability of an Internet-based decision aid (myAID) for patients with ulcerative colitis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 32, pp. 130 - 130, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100236&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Kamm MA; Walsh AJ; Van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Kaakoush N, 2016, 'Multi donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: a randomised placebocontrolled trial and microbiota analysis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 31, pp. 143 - 143, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700253&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Kaakoush NO; Kamm MA; Faith JJ; Clemente JC; Walsh AJ; Van den Bogaerde J; Samuel D; Leong RWL; Connor S, 2016, 'Faecal microbiota transplantation (FMT) in ulcerative colitis is associated with specific bacterial changes: stool and colonic mucosa 16S microbiota analysis from the randomised controlled FOCUS study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 31, pp. 125 - 126, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700223&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bye W; Sparrow M; Connor SJ; Andrews JM; Ellard K; Ng W; Hume G; Antoniades S; Walsh AJ, 2016, 'Identifying 'at-risk' inflammatory bowel disease patients who may be targeted with a new adjuvant herpes zoster subunit vaccine', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 10, pp. S365 - S366, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374496600644&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Paramsothy S; Kamm M; Walsh A; van den Bogaerde J; Samuel D; Leong R; Connor S; Ng W; Paramsothy R; Kaakoush N, 2016, 'Multi-donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: a randomised placebo-controlled trial', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 10, pp. S14 - S14, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000374496600018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Julsgaard M; Christensen LA; Gibson PR; Gearry R; Fallingborg J; Kjeldsen J; Wildt S; Svenningsen L; Connell W; Hvas CL, 2015, 'Adalimumab and infliximab levels in neonates (ERA study)', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 9, pp. S2 - S3, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000353811200005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chen J-H; Corte C; Kariyawasam V; Moran N; Gounder P; Collins G; Connor S; Lee TW; Walsh A; Koh CE, 2015, 'Consensus Statements on the Management of Acute Severe Ulcerative Colitis', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 9, pp. S253 - S253, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000353811200465&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Davison SA; Nguyen R; Connor S; Ng W; Dobbins TA; Maley M; Monaharan S; Levy MT, 2010, 'Vitamin D deficiency is common in patients with genotype 1 chronic hepatitis C and is associated with lower rate of SVR', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, Vol. 25, pp. A132 - A132, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1